Along with a decrease in T cell priming in both primary and distant lymph nodes of ENI mice, we observed that mice treated with ENI had a decrease in dendritic cells (DCs) (CD11c+MHCII+ cells) in the primary tumor DLNs (Fig. 2H). This evidence concerns the gene ITGAX and neoplasm.